Neuroimmunology
Tumefactive demyelinating lesions
Jun. 01, 2024
This is an image preview.
Start a Free Account
to view the full image.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
US national prevalence rate of adults with elevated blood lead levels by state (2013)
Prevalence rate of adults with blood lead levels (BLLs) of 10 µg/dL or higher, by state (State Adult Blood Lead Epidemiology and Surveillance programs, United States, 2013).
Notes:
(1) Rate per 100,000 employed adults aged 16 years or older. State-resident prevalence rate might be lower for some states. Data from the Adult Blood Epidemiology and Surveillance Program, National Institute for Occupational Safety and Health. Denominators for 2013 were extracted from the 2015 U.S. Department of Labor, Bureau of Labor Statistics, Local Area Unemployment Statistics program.
(2) The national rate in 2013 was 20.4 cases per 100,000 employed adults aged 16 years or older. A total of 30 states submitted data in 2013: Alabama, Alaska, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New Mexico, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Vermont, Washington, Wisconsin, and Wyoming. Massachusetts provided data for BLLs 25 µg/dL or higher. In 2013, Missouri (111.8) and Iowa (53.7) reported the highest prevalence rates of elevated blood lead levels.
(Source: Alarcon WA; State Adult Blood Lead Epidemiology and Surveillance [ABLES] Program Investigators. Elevated blood lead levels among employed adults - United States, 1994-2013. MMWR Morb Mortal Wkly Rep 2016;63[55]:59-65. Public domain.)